Document is current
Any future updates will be listed below
-
Authors
Philippot, Quentin https://orcid.org/0000-0003-3429-9605
Fekkar, Arnaud
Gervais, Adrian
Le Voyer, Tom
Boers, Leonoor S.
Conil, Clément
Bizien, Lucy
de Brabander, Justin
Duitman, Jan Willem
Romano, Alessia
Rosain, Jérémie
Blaize, Marion
Migaud, Mélanie
Jeljeli, Maxime
Hammadi, Boualem
Desmons, Aurore
Marchal, Astrid
,
Nossent, Esther J.
Saris, Anno
De Vries, Heder
Meijboom, Lilian J.
Blok, Siebe G.
Schuurman, Alex R.
Reijnders, Tom D. Y.
Hugenholtz, F.
Vallejo, Juan J. Garcia
Bontkes, Hetty
Vlaar, Alexander P. J.
Wiersinga, Joost
Lutter, René
van der Poll, Tom
Bogaard, Harm Jan
Kullberg, Robert F. J.
Zhang, Shiqi
Nossent, Esther J.
Heunks, Leo M. A.
Tuinman, Pieter Roel
Bonta, Peter I.
,
Abel, Laurent
Al-Muhsen, Saleh
Arias, Andrés A.
Bogunovic, Dusan
Bolze, Alexandre
Bousfiha, Ahmed A.
Mansouri, Davood
Meyts, Isabelle
de Diego, Rebeca Perez
Sancho-Shimizu, Vanessa
Spaan, András N.
Tangye, Stuart G.
Zhang, Shen-Ying
Su, Helen C.
Mayaux, Julien
Zhang, Qian
Jouanguy, Emmanuelle
Borie, Raphael
Crestani, Bruno
Luyt, Charles Edouard
Adle-Biassette, Homa
Sene, Damien
Megarbane, Bruno
Cobat, Aurélie
Bastard, Paul
Bos, Lieuwe D. J.
Casanova, Jean-Laurent
Puel, Anne
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01AI088364, R01AI163029)
NIH Clinical and Translational Science Award (UL1TR001866)
French National Research Agency (ANR) under the “Investments for the Future” (ANR-10-IAHU-01)
Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence (ANR-10-LABX-62-IBEID)
French Foundation for Medical Research (EQU201903007798)
ANR GENVIR (ANR-20-CE93-003)
ANR AABIFNCOV (ANR-20-CO11-0001)
ANR-RHU COVIFERON Program (ANR-21-RHUS-08)
FRM (EA20170638020)
Amsterdam UMC through the fellowship program
European Respiratory Society (ARDS gold medal)
- License Information
-
More Information
Article History
Received: 5 January 2023
Accepted: 3 May 2023
First Online: 20 May 2023
Declarations
:
: The study was approved by the institutional ethics committees of The Rockefeller University and Necker Hospital for Sick Children, and was performed in accordance with the requirements of these bodies.
: Informed consent for participation in this study was obtained in accordance with local regulations, with approval from the institutional review board (IRB).
: Not applicable.
: RB has given lectures for Boehringer Ingelheim, Roche and Sanofi. JLC is an inventor on patent application PCT/US2021/042741, filed July 22, 2021, submitted by The Rockefeller University that covers diagnosis of susceptibility to, and treatment of, viral disease and viral vaccines, including COVID-19 and vaccine-associated diseases. The other authors declare that they have no conflict of interest related to this study.
